A new NGS-based method for chimerism monitoring
In this case study, you will hear Dr. Dan Hauzenberger, Medical Director, Section of Transplantation Immunology at Sweden’s Karolinska University Hospital, describing how new, highly sensitive, and precise methods for mixed chimerism analytics are transforming post-transplant monitoring, enabling earlier detection and treatment to save the lives of transplanted.
- Very early detection of relapse is possible thanks
to high sensitivity and accurate measurement
down to 0.05% minority fraction chimerism. - Fast and easy workflow from patient sample to report.
- One tube NGS library prep with just 45 minutes
hands-on time combined with powerful and
intuitive data analysis and reporting software.
Get access to the case study by filling out the form below
Related content
View allDevyser publishes annual report for 2023
Devyser´s annual report 2023 has today been published on the company´s website. The report is...
Read More
Devyser achieves breakthrough in the US with cystic fibrosis NGS test
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Read More
Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patients
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Read More